The Catalyze Preclinical Services Program focuses on those services not typically available through the Catalyze Product Definition R61/R33 awards. The Catalyze Preclinical Services Program supports activities for technology development of products that are at end-stage proof-of-concept through preclinical development and US regulatory approval. Additional information can be found within the preclinical webinar presentation slides.
The Catalyze Preclinical Services Program focuses on those services not typically available through the Catalyze Product Definition R61/R33 awards. The Catalyze Preclinical Services Program supports activities for technology development of products that are at end-stage proof-of-concept through preclinical development and US regulatory approval. Additional information can be found within the preclinical webinar presentation slides.